Rivista
/
Ricerca sul cancro
/
Profilage de la sensibilité aux thérapies ciblées dans les organoïdes dérivés de patients atteints de CPNPC mutants EGFR
JoVE Journal
Ricerca sul cancro
This content is Free Access.
JoVE Journal Ricerca sul cancro
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Please note that all translations are automatically generated. Click here for the English version.

Profilage de la sensibilité aux thérapies ciblées dans les organoïdes dérivés de patients atteints de CPNPC mutants EGFR

3,451 Views

•

08:52 min

•

November 22, 2021

DOI:

10.3791/63039-v

DOI:
10.3791/63039-v

•

08:52 min
November 22, 2021

•

2 Views
, , ,
1Department of Medicine,University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center,University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology,University of California, San Francisco

Tags

OrganoidsEGFR-mutant NSCLCTargeted TherapiesMatrigelCell CultureDissociationTrypsinizationCentrifugationCell CountingCell Suspension96-well Plate

Read Article

Cite this Article

Barbosa Rabago, D., Blakely, C. M., Haderk, F., Bivona, T. G. Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids. J. Vis. Exp. (177), e63039, doi:10.3791/63039 (2021).

Download .ris file

Copy

Share Video

.

Copy